Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
March 18, 2002
- REGULATORY NEWS IN BRIEF
March 18, 2002
- Committee to Propose Intellectual Property Strategy by Summer
March 18, 2002
- New NHI Prices to Be Effective on April 1
March 18, 2002
- Pravastatin Is Beneficial for Postmenopausal Hyperlipidemia: Seminar
March 18, 2002
- Korosho's PAL Amendment Bill Approved by LDP
March 18, 2002
- Evidence-Based Infection Control GL Established
March 18, 2002
- Sales of Bonalon Remain at 60% of Target
March 18, 2002
- ICH Meeting in Brussels Reported by Korosho
March 18, 2002
- Eisai Aims at Sales of \550 Bil. in FY2006: President Naito
March 18, 2002
- Reform Must Be Carried Out at Any Cost: Health Minister
March 18, 2002
- Giving Employees the Dream of Creating Major Firm: Mr Mascarenhas of Eli Lilly Japan
March 18, 2002
- Healthcare Reform Bills Approved by Government
March 18, 2002
- WORLD NEWS IN BRIEF
March 18, 2002
- BUSINESS NEWS IN BRIEF
March 18, 2002
- MEDICAL DEVICE NEWS IN BRIEF
March 18, 2002
- DIAGNOSTIC NEWS IN BRIEF
March 18, 2002
- Glaucoma Testing Not Conducted in 80% of Municipalities in Tokyo
March 11, 2002
- BUSINESS NEWS IN BRIEF
March 11, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
March 11, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…